▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Cullinan Therapeutics (NASDAQ: CGEM)

$7.85

(1.4%)

$0.11

Price as of October 15, 2025, 11:13 a.m. ET

Cullinan Therapeutics Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
CGEM	-52.31%			-74%
S&P	+13.39%	+90.75%	+13.79%	+74%

Cullinan Therapeutics Company Info

Cullinan Oncology, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

News & Analysis

Featured Article

Cullinan (CGEM) Q2 R&D Jumps 68%

Motley Fool Markets Team | Aug 7, 2025

Featured Article

Why Shares of Cullinan Oncology Jumped This Week

The company's presentation at a conference got the attention of analysts and investors.

James Halley | Jun 9, 2023

Why Cullinan Oncology Stock Is Skyrocketing Today

Keith Speights | Jun 4, 2021

The company announced encouraging clinical data for its experimental lung cancer drug.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services